Studien & Berichte
5. Sept. 2026•1 Min. Lesezeit
Parkinson’s Disease: Pathology, Symptoms, and Current Treatment Options
Parkinson’s disease is a neurodegenerative disorder marked by dopamine neuron loss and Lewy bodies, causing motor and non‑motor symptoms; treatment includes dopamine therapy and deep brain stimulation.
1
Studien & Berichte
5. Sept. 2026•1 Min. Lesezeit
Parkinson’s disease: dopamine therapy limits and emerging non‑motor symptom concerns
Levodopa remains effective for motor symptoms of Parkinson’s disease, but long‑term use brings motor fluctuations and a range of non‑motor issues that heavily impact patients.
Studien & Berichte
4. Sept. 2026•1 Min. Lesezeit
Study Links Long-Term Soccer Play to Brain Atrophy and Mood Issues
Preliminary research presented at the AAIC suggests former professional soccer players show greater brain atrophy and higher rates of depression and anxiety than the general population.
Studien & Berichte
4. Sept. 2026•1 Min. Lesezeit
Dong-A ST Presents Nonclinical Data on GPX4 Activator DA-7505 and Tau Inhibitor DA-7503 at AAIC
Dong-A ST disclosed nonclinical results for its Alzheimer’s drug candidates targeting ferroptosis (DA-7505) and tau aggregation (DA-7503) at the AAIC in London.
Studien & Berichte
31. Aug. 2026•1 Min. Lesezeit
NCIA Highlights Autophagy‑Based Brain Health Strategy and Launches NeuroAP Supplement
NCIA presented autophagy‑focused brain health research and unveiled the pharmacy‑only supplement NeuroAP at a Daegu pharmacist fair, with KAIST professor Park Ok‑nam discussing autophagy’s role in neurodegeneration.